| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 401.19 mm | 401.19 mm | 401.19 mm | 401.19 mm | 401.19 mm | 401.19 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 22.30 mm | 18.73 mm | 16.41 mm | 12.47 mm |
| Cash used (since last report) | n/a | n/a | 33.41 mm | 28.06 mm | 24.59 mm | 18.69 mm |
| Cash remaining | n/a | n/a | 367.79 mm | 373.13 mm | 376.60 mm | 382.51 mm |
| Runway (months of cash) | n/a | n/a | 16.5 | 19.9 | 22.9 | 30.7 |
| 13F holders | Current |
|---|---|
| Total holders | 202 |
| Opened positions | 33 |
| Closed positions | 31 |
| Increased positions | 89 |
| Reduced positions | 57 |
| 13F shares | Current |
|---|---|
| Total value | 2.73 tn |
| Total shares | 91.73 mm |
| Total puts | 20.30 k |
| Total calls | 21.50 k |
| Total put/call ratio | 0.9 |
| Largest owners | Shares | Value |
|---|---|---|
| FMR | 11.27 mm | $395.69 bn |
| BLK BlackRock | 6.81 mm | $239.02 bn |
| FHI Federated Hermes | 4.86 mm | $170.49 bn |
| Vanguard | 4.27 mm | $149.81 bn |
| JHG Janus Henderson | 4.08 mm | $143.10 bn |
| T. Rowe Price | 3.74 mm | $131.44 mm |
| Biotechnology Value Fund L P | 3.48 mm | $150.54 mm |
| STT State Street | 2.87 mm | $100.92 bn |
| Boxer Capital | 2.20 mm | $77.34 bn |
| Capital Research Global Investors | 2.16 mm | $76.00 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 26 Sep 24 | Douglas B. Snyder | Stock Option Common Stock | Grant | Acquire A | No | No | 30.5 | 140,000 | 4.27 mm | 140,000 |
| 27 Jun 24 | Throne Jason | Common Stock | Option exercise | Acquire M | No | No | 7.01 | 47,060 | 329.89 k | 63,484 |
| 27 Jun 24 | Throne Jason | Common Stock | Option exercise | Acquire M | No | No | 13.34 | 6,424 | 85.70 k | 16,424 |
| 27 Jun 24 | Throne Jason | Stock Option Common Stock | Option exercise | Dispose M | No | No | 7.01 | 47,060 | 329.89 k | 1,360 |
| 27 Jun 24 | Throne Jason | Stock Option Common Stock | Option exercise | Dispose M | No | No | 13.34 | 6,424 | 85.70 k | 41,186 |
| 31 May 24 | Catherine J Mackey | Stock Option Common Stock | Grant | Acquire A | No | No | 36.55 | 16,200 | 592.11 k | 16,200 |
| 31 May 24 | Hampton Malcolm Garret | Stock Option Common Stock | Grant | Acquire A | No | No | 36.55 | 16,200 | 592.11 k | 16,200 |
